News

Phase I trial demonstrates lasting responses and encouraging safety profile in two aggressive thyroid cancer subtypes, ...
After finding her parents dead at their home in Essex, daughter Ellie Baxter's nightmare began as she became the main suspect ...
Struggling to lose weight? Discover 4 hidden hormonal reasons blocking your progress and learn how to address them ...
Among the 329 patients included in the analysis, the mean age was 53±13 years, and 74% were women. The average duration of ...
Differentiated thyroid cancer patients who receive radioiodine (RAI) treatment after surgery have increased relative survival ...
In a special role reversal, Back to Health Functional Medicine doctor Dr. Anya Szigeti flipped the script and sat down with ...
An interdisciplinary research team has unveiled the world's first artificial intelligence (AI) model designed to classify both the cancer stage and risk category of thyroid cancer, achieving ...
These natural ebbs and flows are appropriate and fine, says Elena Christofides, MD, an endocrinologist in Columbus, Ohio.
Pedro C. Barata, MD, MSc, discusses the use of darolutamide in patients with hormone-sensitive prostate cancer.
An interdisciplinary research team has unveiled the world's first artificial intelligence (AI) model designed to classify ...